Home

Jagsonpal Pharmaceuticals Ltd EPS

Image

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM

EPS

₹ 5.49

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Jagsonpal Pharmaceuticals Ltd is ₹ 5.49 as of 21 Feb 25 .
  • The earning per share of Jagsonpal Pharmaceuticals Ltd changed from ₹ 2.85 to ₹ 4.74 over 7 quarters. This represents a CAGR of 33.74% .

Historical Earning per Share of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Jagsonpal Pharmaceuticals Ltd

Market Cap

1,456 Cr

EPS

5.5

P/E Ratio (TTM)

40.0

P/B Ratio (TTM)

7.4

Day’s High

228.1

Day’s Low

217.05

DTE

0.0

ROE

13.6

52 Week High

328.02

52 Week Low

108.02

ROCE

17.5

Market Price of Jagsonpal Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jagsonpal Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025219.45
20 Feb 2025218.7
19 Feb 2025214.15
18 Feb 2025215.8
17 Feb 2025220.85
14 Feb 2025229.95
13 Feb 2025229.25
12 Feb 2025241.05
11 Feb 2025220.3
10 Feb 2025241.8

SWOT Analysis Of Jagsonpal Pharmaceuticals Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Jagsonpal Pharmaceuticals Ltd

Asset Value vs Market Value of Jagsonpal Pharmaceuticals Ltd

Market Value

1,456

Asset Value

Value addition

6.2 X

202

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Jagsonpal Pharmaceuticals Ltd1456
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Jagsonpal Pharmaceuticals Ltd News Hub

Jagsonpal Pharmaceuticals AGM scheduled

Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting (AGM) of the company will b

Read more

13 Aug 24

Jagsonpal Pharmaceuticals standalone net profit declines 28.74% in the June 2024 quarter

Net profit of Jagsonpal Pharmaceuticals declined 28.74% to Rs 5.33 crore in the quarter ended June 2

Read more

08 Aug 24

Jagsonpal Pharmaceuticals declare Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 August 2

Read more

01 Aug 24

Jagsonpal Pharmaceuticals to table results

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23 October

Read more

17 Oct 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Jagsonpal Pharmaceuticals Ltd

What is the EPS of Jagsonpal Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Jagsonpal Pharmaceuticals Ltd is 5.49. An EPS is the amount of net income attributed to each share of a common stock.

How is Jagsonpal Pharmaceuticals Ltd EPS calculated?

The EPS of Jagsonpal Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Jagsonpal Pharmaceuticals Ltd report its EPS?

Jagsonpal Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Jagsonpal Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Jagsonpal Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Jagsonpal Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Jagsonpal Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions